Haemonetics Presentation

Haemonetics Corporation

New Hire Presentation

*NARRATOR:Welcome to Haemonetics! This presentation has been created to provide a broad overview to newly hired employees, staff members of acquired companies and those interested in learning more about us.

*

HAEMONETICS CORPORATION COMPANY CONFIDENTIAL

AgendaCompany Vision

Corporate Strategies

Dynamic Industry

Businesses and Products

Core Competencies

Company Values

Blood Facts

*NARRATOR:This overview includes information that will help you understand our vision and strategies, the industries in which we conduct business, the products and services that we provide, and the core competencies and company values that make us successful. As you will see, our products and services are focused on ensuring the availability and safety of the worlds blood supply.

*


Our VisionHaemonetics Is The Global Leader In Blood Management Solutions For Our Customers

*NARRATOR: Our vision is to be the global leader in blood management solutions for our customers. For more than thirty years, we have been offering world class automated blood processing systems. Today, our vision carries on this legacy by delivering a suite of blood management solutions.

*


Leverage The Business For

Improved ProfitabilityCorporate StrategiesExpand The Business By Leveraging

Our Core Competencies

*NARRATOR: To make our vision a reality, we consistently execute two corporate strategies: Leverage the business for improved profitability and Expand the business by leveraging our core competencies

We have been very successful at leveraging the business and improving profitability and in the process, creating significant shareholder value.

We have expanded our business by leveraging our core competencies to launch new products and acquire new technologies.

Our Corporate Strategies have allowed us to achieve a level of success that is unmatched in our industry and shared only with a select group of medical device companies. As we look to the future, the roadmap to continued success is built upon the execution of our corporate strategies.

*


Increased demand for safer, higher quality blood

Donor recruitment and retention continues to decline

Financial profitability of blood banks is marginal

Hospitals have limited visibility to blood costs

Dynamic IndustryOur Customers Have Challenging Blood Needs

*NARRATOR:We operate within a very dynamic industry. Our customers rely on us to provide solutions that will allow them to overcome multiple challenges. These challenges include: Regulatory complianceFewer donorsLimited financial profitabilityand costs

Our customers need more than high quality, reliable medical devices. They need a comprehensive solution that addresses all their blood management needs and allows them to achieve their business goals.

*


Industry Trend #1 Blood Shortages More Frequent and Widespread

Increased donor restrictions (tattoos, piercings)Increased scrutiny of foreign travel

Fewer people willing to donate

*NARRATOR: There are three trends which underscore the dynamic nature of the blood processing industry. The first trend is chronic blood shortages. The number of blood donations are on the decline due to increased donor restrictions and fewer people willing to donate. At the same time, the number of blood transfusions are increasing due to an aging population receiving more complicated surgeries and more comprehensive treatments. This trend has serious complications for patients who depend on blood transfusions.

*


Industry Trend #2Increasing Demand For Safer BloodTransfusion risks

Intense regulatory scrutiny

Increased blood testing requirements

Increased scrutiny of blood collection processes

*NARRATOR: The second trend is the demand for safer, higher quality blood products. Since the mid nineteen eighties when blood was discovered to transmit HIV, the public has demanded assurances of a safe blood supply. To do this, regulatory bodies have increased regulatory scrutiny and blood testing requirements.

Unlike other medical devices, the operators of blood related medical devices must receive regulatory approval to operate a device. All of the processes used to collect, store, manufacture and distribute blood components also receive regulatory scrutiny.

*


Industry Trend #3Higher quality standardsAdditional blood testing requirementsMany blood centers operating at a lossHospitals paying more fees for blood

Increased Collection and Transfusion Costs

*NARRATOR: The third trend in the marketplace is the building cost pressures for both blood collectors and hospitals. The dual forces of a shrinking donor pool and increasing demand for safer blood creates additional costs. Donor recruitment, blood collection equipment, phlebotomy staff, regulatory testing mandates, and label and storage requirements all contribute to higher collection costs.

*


Integrated Blood Management SolutionDonorCollectionInventoryPatient

Arm to Arm Blood Supply Chain Management

Clinical and Economic BenefitsEffective Partnership With Blood SupplierTesting & SeparationTesting & Preparation

*NARRATOR:Haemonetics response is to offer an integrated suite of products and services that address all the challenges present across the blood supply chain. Working in tandem, our products and services deliver an Integrated Blood Management Solution that responds to the needs of blood collectors, hospitals and patients.

Next we will discuss how our products and services respond directly to these industry trends.

*


Haemonetics ResponseApheresis DonorsRequiredTo Donate Blood Components BelowWhole Blood Donors Required2 units platelets1 unit platelets; 1 unit plasma1 units platelets1 unit red cells; 2 units plasma2 units plasma2 units red cells Collect More From Fewer Donors

*NARRATOR:A shrinking donor pool creates a challenge to meet the demand for blood transfusions. Haemonetics response is to increase the collection yield from the existing donor pool. This is done by maximizing the number of blood components collected from one blood donation. Our automated apheresis blood collection technology significantly increases the yield of blood components.

*


Haemonetics ResponseGo To Where The Donors Are

*NARRATOR:Another way that we respond to the blood shortage trend is to provide mobile blood collection systems. The majority of blood collections are performed away from blood centers. Haemonetics blood collection technology is designed with mobility in mind. Our mobile automation technology travels to where the donors are and provides an easy-to-use environment for both operators and donors.

*


Haemonetics Response

Improved regulatory complianceProduction standardizationCost effective

ManualAutomatedCollection Automation

*NARRATOR: Our automated technology allows our customers to cope with the challenging regulatory world in which they operate. Regulatory agencies have identified collection automation as a way to improve quality. Automated collections offer better quality control over the blood component.

*



Train centers on how to maximize collections in mobile drives

Improve donor recruitment capabilities

Implement software that: Automates donor recruitment and donor screening processesReduces units wasted due to human errorProcess Automation

*NARRATOR:Haemonetics has acquired an expertise in developing efficient business processes using Six Sigma and Lean methodologies. We offer these same tools to our customers. Additionally, our suite of software automation products are designed specifically for improving blood management practices. Automating these processes allows our customers to reduce costs, eliminate errors, improved operational efficiencies and achieve regulatory compliance.

*



Eliminate unnecessary donor blood transfusionsClinical benefit to patientCost benefit to hospitalCell Salvage

*NARRATOR:Haemonetics cell salvage technology reduces the need for blood transfusions and improves patient outcomes. Hospitals are under tremendous pressure to maintain adequate blood inventory levels to satisfy transfusion needs. Our Cell Salvage technology reduces the demand for blood transfusions which reduces the costs to maintain blood inventories. Cell salvage also reduces the risks associated with transfusion related complications which can lead to longer hospital stays.

*


Haemonetics Businesses & ProductsDonorCommercial PlasmaPatient Software Solutions & ServicesEmerging Technology & Diagnostics (Arryx)

*NARRATOR:Haemonetics businesses and products are focused in five segments: the Donor market, Commercial Plasma, the Patient market, Software Solutions & Services and Emerging Technology.

Next we will discuss each of these businesses and products.

*


Donor Products Automate Collection Of Platelets And Red Cells For TransfusionDonor

*NARRATOR:Donor products automate collection of platelets and red cells for transfusion. Donor customers are principally not-for-profit blood collectors and blood banks who collect red cells and platelets from volunteer donors. In many countries blood collection and blood banks are a branch of a national healthcare system. In the United States the American Red Cross accounts for approximately 46% of blood collections. The balance is collected by independent not-for-profit blood banks.

The Donor Division business model is to place devices at blood collection locations and sell the single use disposable set which is required for each donor collection.

*


Blood Bank Product Line

MCS + 9000 Competitors: Caridian BCT, Fenwal ACP 215

*NARRATOR:The blood bank product line is part of the Donor Division. Platelets, the blood component that aids in clotting, are most often used for transfusion to cancer patients whose own platelets have been damaged or destroyed by chemotherapy. The MCS+ 9000 system automates the collection of 1 to 2 units of platelets from a donor.

The ACP215 represents a major breakthrough in cell processing. This device prepares red blood cells for freezing using glycerol. Frozen red cells can be used for transfusion for at least 10 years after freezing. Cell washing removes the glycerol and most of the plasma proteins which reduces the risk of a negative reaction.

*


MCS + 8150Red Cell Product LineCompetitor: Fenwal

Cymbal

*NARRATOR: The red cell product line is also part of the Donor Division. Red blood cells are the most frequently transfused blood component and are essential for many types of surgeries and medical treatments. The MCS+ 8150 and Cymbal systems automate the collection of two units of red cells. The Cymbal device is engineered for mobile blood collections. Both systems collect two units of red cells from one donor which allows collection agencies to double their red cell yield.

*


Plasma Products Automate Collection Of PlasmaPlasma

*NARRATOR: Plasma is a straw-colored liquid that carries red blood cells, white blood cells and platelets. Plasma makes up 55% of blood and is collected primarily for manufacture into biopharmaceutical products. The process of manufacturing plasma into biopharmaceuticals is called fractionation. Over 25 million liters of plasma are fractionated annually worldwide. Plasma also benefits trauma patients, transplant recipients, and patients with clotting disorders.

*


Plasma Product PCS2Competitor: Fenwal

*NARRATOR:The PCS2 system is Haemonetics' technology for the collection of plasma. This device Flexible protocols allow for the collection of "jumbo" units of platelet-poor plasma and platelet-poor plasma with optional saline replacement. The system is compact, lightweight, and user-friendly with built-in safety features.

*


Patient Products Automate Suction And Blood Collection In SurgeryPatient

*NARRATOR:Now lets discuss our Patient Division. Patient products automate suction and blood collection during and after surgery. This process, also known as surgical blood salvage or auto-transfusion, allows for blood lost during or after surgery to be collected, cleaned, and made available for re-infusion to the patient. This process is used worldwide in more than one million surgeries each year.

*


Patient ProductsHarmonyCompetitors: Medtronic, Sorin, FreseniusCell Saver

*NARRATOR: The flagship of the Haemonetics auto transfusion product line is the Cell Saver. This system is the standard for blood salvage during rapid or high blood loss surgeries. It is designed for use in open heart surgery, vascular surgery, total joint replacement, spine surgery, trauma, and transplant surgery. Haemonetics invented surgical blood salvage nearly thirty years ago and has been an innovator in the field ever since.

The SmartSuction Harmony is a surgical blood suction system used to clear blood, fluid and debris from the surgical field. The system provides high air flow, self-regulating suction that optimizes removal of fluid at low suction levels. The device works as a companion product with our suite of blood salvage systems.

*


Patient ProductsCompetitors: Medtronic, Sorin, FreseniusOrthoPATCardioPAT

*NARRATOR: The OrthoPAT is designed specifically to meet the auto transfusion needs of orthopedic surgery patients. This device provides both intraoperative and postoperative blood salvage. The OrthoPAT system is revolutionary in that orthopedic surgical patients, who historically have had to depend on donated blood, can now easily utilize their own blood.

The CardioPAT system is designed to meet the autotransfusion needs of cardiovascular surgery patients. Similar to the OrthoPAT, this device provides both intraoperative and postoperative blood salvage in a single disposable set. Both systems utilize Haemonetics dynamic disk technology.

*


Patient ProductsTEG 5000

*NARRATOR: The TEG 5000 is the most comprehensive hemostasis analyzer available to clinicians to help prevent blood clotting complications. This product improves patient outcomes by reducing the need for allogeneic blood transfusions and benefits hospitals by preserving blood inventories.

*


Software and ServicesSoftware ApplicationsBusiness SolutionsBlood Management Consulting

*NARRATOR: Now lets move to Software and Services. The Software and Services division provides hospitals and blood collectors with software applications, business services and blood management consulting. Our software and services are geared towards optimizing blood center and hospital processes and improving the effectiveness of the overall blood supply chain.

*


Located in Rosemont, IL and Edmonton, Alberta

Core Competency - software applications that aid in: Donor management and recruitment Blood component managementFederal guideline compliance

Haemonetics Software Solutions Co.

*NARRATOR:Our software applications act as the main computer system or database that stores and manages all activities within a blood bank or plasma collection center. Regulatory mandates require rigorous controls to ensure that donor candidates are suitable for blood donation. Tight controls are also required for testing, quarantining, separating blood into its components and for releasing blood for transfusion. The entire process from qualifying donor candidates to releasing blood for transfusion is tracked by our software. The dependency on our software to achieve regulatory compliance is so high that the applications themselves are considered a medical device.

*


Commercial products:

Haemonetics Software Solutions Co.Competitors: MAK Systems, Global Med, Mediware

31.bin

32.bin

*NARRATOR: Our commercial software products are eQue, Symphony, eLynx and Surround. eQue is a self-administered donor registration system, health history questionnaire and assessment tool that assists blood banks and plasma centers in determining donor eligibility. The eQue system works in both fixed and mobile blood drive environments.

The Symphony Suite gives blood centers both functionality and flexibility to track all donor, donation and blood unit information with the ability to accommodate increasingly stringent regulatory requirements.

eLynx is a hand-held system used by blood banks and plasma centers to automate donation floor operations and electronically capture real-time information. The system can be used for whole blood and apheresis collections and eliminates much of the paperwork traditionally found in donor operations.

And finally, Surround is an application used by blood laboratories to track samples and test results. Surround provides a secure, adaptable and reliable platform to handle time-critical and highly regulated laboratory needs.

*


Blood Management Consulting

Step by step approach to blood management by patient type and serviceBest practices comparison of hospitals clients blood practiceMulti-dimensional needs assessmentsTailored monthly blood usage reports to hospital executives and physicians.

*NARRATOR:Infonal is our Blood Management Consulting function. It provides IT tools that extract blood usage data from hospital IT systems. Our staff of clinicians and IT specialists use this data to advise surgeons on how to improve transfusion practices. This information is also used to make recommendations on how to utilize blood therapies to treat patients before surgery and to recover patient blood during surgery.

*


Business SolutionsBusiness Process ExcellenceSix SigmaLeanBusiness DesignInsight ModelMobile Efficiency

Donor Recruitment TrainingMarket Research and Customer SurveysCE Provider

*Narrator: We create strategic partnerships with our customers by offering consultative blood management solutions and business process excellence. These solutions allow our customers to deliver an enhanced donor experience and improve their customer service.

We offer innovative programs such as Six Sigma and Lean training, Industry Centric Programs and Customer Specific Programs. Our Six Sigma program implemented with the American Red Cross is credited with achieving $22million dollars in cost savings through improved efficiencies and waste reduction.

The Insight Model is a service provided to our customers that analyzes their blood center data, and makes recommendations on how to grow collections using automation and mobile efficiency.

*


Emerging Technology & Diagnostics

Arryx: Optical Manipulation and Management Holographic Optical Trapping (HOT) Using Light and Holograms to Create Microscopic Tractor Beams

*Narrator:Arryx is our Emerging Technology group. Arryx uses Holographic Optical Trapping technology to move and manipulate microscopic objects. This Holographic Optical Trapping or HOT technology uses laser beams and holograms to independently and in parallel hold, move, separate and manipulate hundreds of nanoscopic objects. The HOT technology is already a powerful laboratory tool used by researchers today. Future applications include blood screening and blood diagnostics as well as non-healthcare related applications.

*


North AmericaMassachusetts, USAPennsylvania, USASouth Carolina, USAIllinois, USAChico, CAAlberta, CanadaAsiaJapanChinaIndiaKoreaTaiwan

EuropeAustriaBelgiumCzech RepublicFranceGermanyItalyNetherlandsRussiaScotlandSwedenSwitzerland

World Wide Locations

*

NARRATOR: Moscow, Russia, India, Chico, Vancouver, San Paolo, That concludes the review of our products and services. Now lets discuss where we are located. To support the global demand for our products and services, we have a global infrastructure consisting of over twenty locations throughout the world. Our corporate offices are located in the United States in Braintree, Massachusetts and we have regional offices in Signy, Switzerland, Tokyo, Japan and Hong Kong. In addition, we have sales and distribution facilities throughout the globe conducting business in more than 50 countries.

Our products our manufactured at company owned facilities in the United States and Scotland, we have relationships with several contract manufactures in Southeast Asia and we work with close to 100 Independent Distributors located on over 65 countries.

*


Global Business

Products & Services Are Sold Globally

*NARRATOR: We market our integrated blood management solution on a worldwide scale. As such, our revenues are distributed among various regions of the globe including North America, Europe and Japan and Asia. In the future, the distribution of revenue may shift as emerging markets continue to develop and existing markets continue to mature. Haemonetics is prepared to meet the changing global demand for blood management solutions.

*


Core CompetenciesWhat Are They? A core competency is a well-performed, unique, internal activity or process that is central to the companys competitiveness and profitability. It contributes significant value, confers a competitive advantage, and provides access to other market opportunities.

How Are They Used? Core competencies drive new product and service offerings that deliver high quality growth, improve profitability and increase shareholder value.

*NARRATOR:Since our inception, Haemonetics has developed Core Competencies that have been central to delivering high quality products and services that meet or exceed customer demands. A Core Competency is defined as a well performed, unique, internal activity or process that contributes significant value, confers a competitive advantage, and provides access to other market opportunities.

While our Core Competencies have greatly impacted our past achievements, they also represent the building blocks for future achievements. Core Competencies are critical to our continued success because they drive new product and service offerings that will deliver high quality growth, improved profitability and increased shareholder value.

Our Core Competencies have allowed us to achieve many significant and noteworthy accomplishments. As a company, we take pride in our Core Competencies and recognize their value, not only in what we they have enabled us to accomplish but also in what they will enable us to achieve in the future.

*


Haemonetics Core CompetenciesManufacturingMarket InnovationCustomer Service

*NARRATOR:Haemonetics has three core competencies. They are: Market Innovation, Manufacturing and Customer Service. Together, they work in unison to deliver value to customers, patients and shareholders. Lets look at each core competency individually.

*


Core Competency Market Innovation

1972Latham BowlBlow Molded Bowl1984Dr. Jack Latham1971Model 30 - Apheresis Market Born1975Cell Saver Cell Salvage Market Born1984PCS Plasma Collection System

*NARRATOR:The first core competency is Market Innovation. Haemonetics has a long history of market innovation. We have created and expanded virtually every market that we do business in. Our founder, Dr. Jack Latham, is regarded as a pioneer in automated blood processing. Through his early work with researchers from Harvard University, Dr. Latham created the first disposable blood processing bowl which led to the creation of the automated blood collection market and the surgical cell salvage market. Haemonetics has expanded these markets by introducing advanced blood processing technologies such as the Blow Molded Bowl and the Dynamic Disk.

*


Core Competency Market Innovation

Dynamic Disk20002004Holographic Optical Trapping 2006Software SolutionsDr. Jack Latham2000OrthoPAT1992MCS Mobile Collection System

*NARRATOR: Our legacy of market innovation has continued to this day. Holographic Optical Trapping is a breakthrough technology that has the potential to reshape how blood collection and cell salvage procedures are performed in the future. The introduction of automated software solutions further advances our evolution into the leading provider of integrated blood management solutions. We have a reputation and an established track record of being a market innovator. We are intent on continuing this leadership into the future by providing integrated blood management solutions.

*


Core Competency - ManufacturingProduct Quality Deliver a product that exceeds customer expectations.

Product AvailabilityEnsure that products are available for all customers worldwide.

Cost Continuously work on improving productivity and efficiency company wide.

*NARRATOR:Our second core competency is manufacturing. We are constantly monitoring our manufacturing processes to ensure the highest product quality, the highest product availability and lowest production costs. Central to our manufacturing competency is a focus on these three priorities. Manufacturing establishes clear goals relative to these three measurements and reviews them regularly to ensure broad alignment, ownership, and accountability.

*


Manufacturing Quality

47.bin

*NARRATOR:Quality expectations are established annually, driving continuous improvement in customer outcomes. This has been critical to our increasing market share in established businesses. At Haemonetics, Quality and Safety trumps all else. Key to achieving high quality production results are designing product quality into the production process, understanding and investing in key production technologies, quality training for all employees and employee involvement.

*


Manufacturing Availability

Tight Communication Process Between Sales Planning, Production Planning, Distribution and Logistics

Strategic Warehouse Locations To Support Our Customer Base

Controlled Target Inventory To Support Unforeseen Product Needs For Our Customers

Geographic Manufacturing Focus

*NARRATOR:Haemonetics operates in a dynamic global market. Ensuring that the right product, at the right time, to the right locations is no easy task. To do this we have developed an integrated processes to collect market signals and drive manufacturing and logistic activities. We maintain global distribution centers in the U.S., Europe, and in Asia to support regional business demands, and we typically maintain between 15 and 30 days of finished product inventory to absorb unplanned shifts in demand.

*


Manufacturing Productivity

Total Quality of Management SystemData driven corrective actionsTeam based problem solvingEmployee training and work assignmentsEmployee reward system for participationQuality and financial drivers to ensure accountabilitySix Sigma measurement system

Change the culture by changing the structure of people work

*NARRATOR: Productivity and high efficiency levels result in lower production costs. We use Lean manufacturing to optimize processes and Six-Sigma tools to drive out variation, resulting in improved quality through more reliable processes. We apply relentless focus on productivity to ensure we are cost competitive in the market place. We have learned that by driving out waste and variability, both cost and quality improve. It is what we do every day.

*


Core Competency Customer Service Reputation for responsiveness

Global presence

In-depth knowledge of the blood management business and processes

Customized and comprehensive program launches

Omega North-Face Award recipient

*NARRATOR:Our third core competency is Customer Service. As a medical device company we are expected to provide superior customer service. Our customers expect that knowledgeable service engineers will come to their site and service their equipment. They expect that orders will be taken accurately and deliveries will be complete and timely. We have a history of exceeding customer expectations and have differentiated ourselves by responding to non-standard requests. It is this kind of responsiveness and quickness to action that has allowed Haemonetics to earn multiple Omega North-face customer satisfaction awards.

*


Core ValuesHaemonetics Core ValuesCustomerFocusPeopleTrust & IntegrityInnovationQuality

*NARRATOR:The heart of our company and the uniqueness of our culture is a reflection of our core values. These values have long been part of our history and support both our vision and our key strategies. They define what we believe in and how we expect to conduct ourselves. Lets take a moment to reflect on each of these.

*


Trust & Integrity

We are committed to doing what is right in our interactions with customers, shareholders, the communities in which we do business and with each other.

*Narrator: Trust and Integrity is our most basic value. We expect Haemonetics employees to make the right choices and to go beyond the letter of the law in all that we do. There simply is no substitute for this and we walk the talk from the CEO to the lowest level of the organization. We try to be straightforward in our communications and transparent about why we make decisions and how we are performing.

*


Customer Focus

Listening to our customers and understanding their needs; consistently delivering superior clinical outcomes and economic value through our technologies, software and services.

*NARRATOR:We exist to serve the needs of our customers and the patients who benefit from our products and services. We pay attention to health care practioners and direct our energy toward creating the products and services that improve patient care and deliver more cost-effective solutions.

*


Innovation

Pioneering leading edge technologies, providing our customers with solutions to their business challenges.

*NARRATOR: Our technology leadership is a function of innovation which started with our founder, Dr Jack Latham. Dr. Latham was inspired to invent a more effective way to collect blood after a friend, who was unable to receive an emergency blood transfusion, lost his life in an industrial accident. That same commitment to creating solutions for our customers drives our innovation efforts today. It drives us to be the global leader in blood management solutions for our customers.

*


Quality

Continuously improving product and business process quality through defined measurements.

*NARRATOR: At Haemonetics we state simply and directly that: Quality is what we do, every day. There is strong resolve to making sure that our products are the safest and most reliable in the world today and that they will be even better tomorrow due to our rigorous attention to continuously improve whatever we make or do.

*


Haemonetics People

Fostering a global culture that demonstrates leadership, encourages employee development, supports teamwork, and recognizes and rewards performance.

*NARRATOR:We are making Haemonetics a great place to work. Our culture is dynamic. Our people around the world are smart, committed and dedicated. And while we all work hard, we also have fun. We pride ourselves on maintaining a strong team-orientation and rewarding performance. We are investing in tools like a state-of-the-art ERP platform and total value proposition sales skills which will help our employees to be fully prepared for a very competitive environment. We are confident in our future. For people who like to work hard and succeed without the drain of organizational politics and a lot of bureaucracy, this is really a great place to be at an extraordinarily exciting time.

*


Haemonetics PeopleTHE BLOOD MANAGEMENT COMPANY


*


Haemonetics People


*


Blood Facts

*NARRATOR:Next we will review blood facts. As mentioned previously, our integrated blood management solutions ensure the availability and safety of the worlds blood supply. To be successful in this effort it is necessary to understand the blood processing industry and the complexities of blood collection and blood salvage.

*


Fact #1Red Blood Cells40-50% of blood volumeCarry oxygen throughout bodyUsed in surgeries and traumasPlateletsSmall percent of blood volumeControl bleedingUsed for cancer and surgical patientsPlasma50% of blood volumeContain proteins which trigger clotting mechanismTransfused directly to patients but frequently used as raw material for pharmaceuticals

Patients Receive Transfusions Of Blood Components, Not Whole Blood

*NARRATOR: Fact number one: Patients who need blood almost never receive transfusions of whole blood. Instead, they receive a transfusion of the blood component that their medical condition requires. Treating medical conditions with blood components is referred to as blood component therapy.

Blood is made up of several components, including: Red Blood Cells, Platelets and Plasma. Red Blood Cells account for approximately 40% of blood volume, carries oxygen throughout the body and is used in surgeries and trauma situations.

Platelets account for the smallest portion of blood volume and are used to control bleeding and to treat cancer and surgical patients.

Plasma accounts for 50% of blood volume and contains proteins which trigger blood clotting. Plasma is transfused directly to patients and is also use as a raw material for biopharmaceuticals.

*


Fact #21) Manual donation of whole blood2) Automated donation of blood components

3) Surgical blood salvageBlood For Transfusion Can Be Processed In Several Ways

*NARRATOR:Fact number two: blood for transfusion can be processed in two very different ways.

The old fashioned way of turning whole blood into blood components is referred to as the manual collection of whole blood.

The more advanced method is to use state-of-the-art technology which automates the collection and separation process.

*


Manual Whole Blood Donation

Bleed by gravity into a bag

Whole blood is batch processed at remote processing laboratorySeparated into three components

*NARRATOR:The manual process for collecting blood components involves having a donor bleed whole blood, by gravity, into a blood bag. The result is a whole blood mixture of red cells, platelets and plasma. The blood bag is delivered to a processing laboratory where it is placed in a washing machine sized centrifuge. After the centrifuge begins spinning, the red blood cells begin to separate from the whole blood. After the first separation, another spin is done to separate the platelets from the plasma. Finally, the bags are squeezed manually until all three components are separated into individual bags. This process is time consuming, labor intensive, expensive and includes many opportunities for human error.

*


Automated Blood Donation

Known as apheresisReal time separationEliminates laboratory processing

64.bin

*NARRATOR: The modern way to collect blood components eliminates the need to separate whole blood after it is collected at a remote laboratory. Instead, the separation is performed on-line while the donor is attached to the blood collection device. In this real time separation method, whole blood is drawn by a pump into a machine which holds a blood processing chamber which acts as a mini centrifuge. We refer to this blood processing chamber as a bowl, which sits inside the medical devices.

*


Automated Collection (Autologous)

Surgical Blood SalvageBlood collected and cleaned during and after surgeryRed blood cells then immediately available for auto-transfusion

The safest blood is your own.

*NARRATOR:The other high-tech way to automate the collection of red cells is to recover whole blood from a surgical patient immediately before, during or post surgery. Red cells that are collected with the whole blood that is shed from the wound are separated, washed, packed and hung on an IV pole and transfused right back to the bleeding patient. This is called surgical cell salvage, or sometimes Intraoperative Autologous Transfusion. Surgical patients who need blood prefer to receive a blood transfusion of their own red cells for the obvious reason that their own blood will never transmit the disease of another blood donor. The blood is fresh, available and always the right blood type.

*


Fact #3Automated Collections Account For Less Than Half Of Blood Collections Worldwide

*NARRATOR:As noted, blood can be collected through manual or automated donations. However, today, the vast majority of red cells for transfusion to patients is still collected through manual methods.

*


Estimated Global Blood CollectionsPlasma 16 millionPlatelet3 millionRed Cell.8 millionSurgical0.8 millionWhole Blood 40 millionAutomated CollectionsManual Collections

*NARRATOR:Blood Fact No 3 is that most blood is manufactured into components using the old fashioned method. Of the 60 million annual world wide blood collection procedures, 40 million are whole blood using manual, non-automated procedures. The whole blood collected using this procedure is then separated into components at the processing lab.

This concludes the general review of blood facts. Now, a final word from Brad Nutter, CEO of Haemonetics.

Welcome to Haemonetics!ArryxBioRyx 200ACP215CymbalA Message From Brian Concannon OrthoPATCardioPATMCS+TEG 5000

70.bin

*NARRATOR:Hello, Im Brian Concannon and let me welcome you to Haemonetics. As you have learned, for over thirty years Haemonetics has worked to establish itself as the global leader in ensuring the safety and availability of the worlds blood supply. In doing so we have earned a reputation for innovation, high quality manufacturing and exceptional customer service. It is these three competencies, driven by the collective efforts of a dedicated, global workforce that will enable us to achieve our vision of being the global leader in blood management solutions for our customers.

Now, this is no small task but one that we are fully confident that we can achieve. We are a company that is uniquely positioned to expand and strengthen our reputation as an innovator in providing healthcare solutions to our customers. Never has Haemonetics been more prepared to deliver exceptional value to our customers, our shareholders and most importantly, our employees.

On behalf of the entire organization, welcome to Haemonetics. You have joined a great corporation with a very bright future. We wish you the best of success in your career and we look forward to working together to achieve our vision.

*NARRATOR:Welcome to Haemonetics! This presentation has been created to provide a broad overview to newly hired employees, staff members of acquired companies and those interested in learning more about us.

*NARRATOR:This overview includes information that will help you understand our vision and strategies, the industries in which we conduct business, the products and services that we provide, and the core competencies and company values that make us successful. As you will see, our products and services are focused on ensuring the availability and safety of the worlds blood supply.

*NARRATOR: Our vision is to be the global leader in blood management solutions for our customers. For more than thirty years, we have been offering world class automated blood processing systems. Today, our vision carries on this legacy by delivering a suite of blood management solutions.*NARRATOR: To make our vision a reality, we consistently execute two corporate strategies: Leverage the business for improved profitability and Expand the business by leveraging our core competencies

We have been very successful at leveraging the business and improving profitability and in the process, creating significant shareholder value.

We have expanded our business by leveraging our core competencies to launch new products and acquire new technologies.

Our Corporate Strategies have allowed us to achieve a level of success that is unmatched in our industry and shared only with a select group of medical device companies. As we look to the future, the roadmap to continued success is built upon the execution of our corporate strategies. *NARRATOR:We operate within a very dynamic industry. Our customers rely on us to provide solutions that will allow them to overcome multiple challenges. These challenges include: Regulatory complianceFewer donorsLimited financial profitabilityand costs

Our customers need more than high quality, reliable medical devices. They need a comprehensive solution that addresses all their blood management needs and allows them to achieve their business goals.*NARRATOR: There are three trends which underscore the dynamic nature of the blood processing industry. The first trend is chronic blood shortages. The number of blood donations are on the decline due to increased donor restrictions and fewer people willing to donate. At the same time, the number of blood transfusions are increasing due to an aging population receiving more complicated surgeries and more comprehensive treatments. This trend has serious complications for patients who depend on blood transfusions.*NARRATOR: The second trend is the demand for safer, higher quality blood products. Since the mid nineteen eighties when blood was discovered to transmit HIV, the public has demanded assurances of a safe blood supply. To do this, regulatory bodies have increased regulatory scrutiny and blood testing requirements.

Unlike other medical devices, the operators of blood related medical devices must receive regulatory approval to operate a device. All of the processes used to collect, store, manufacture and distribute blood components also receive regulatory scrutiny.

*NARRATOR: The third trend in the marketplace is the building cost pressures for both blood collectors and hospitals. The dual forces of a shrinking donor pool and increasing demand for safer blood creates additional costs. Donor recruitment, blood collection equipment, phlebotomy staff, regulatory testing mandates, and label and storage requirements all contribute to higher collection costs.

*NARRATOR:Haemonetics response is to offer an integrated suite of products and services that address all the challenges present across the blood supply chain. Working in tandem, our products and services deliver an Integrated Blood Management Solution that responds to the needs of blood collectors, hospitals and patients.

Next we will discuss how our products and services respond directly to these industry trends. *NARRATOR:A shrinking donor pool creates a challenge to meet the demand for blood transfusions. Haemonetics response is to increase the collection yield from the existing donor pool. This is done by maximizing the number of blood components collected from one blood donation. Our automated apheresis blood collection technology significantly increases the yield of blood components.

*NARRATOR:Another way that we respond to the blood shortage trend is to provide mobile blood collection systems. The majority of blood collections are performed away from blood centers. Haemonetics blood collection technology is designed with mobility in mind. Our mobile automation technology travels to where the donors are and provides an easy-to-use environment for both operators and donors. *NARRATOR: Our automated technology allows our customers to cope with the challenging regulatory world in which they operate. Regulatory agencies have identified collection automation as a way to improve quality. Automated collections offer better quality control over the blood component.*NARRATOR:Haemonetics has acquired an expertise in developing efficient business processes using Six Sigma and Lean methodologies. We offer these same tools to our customers. Additionally, our suite of software automation products are designed specifically for improving blood management practices. Automating these processes allows our customers to reduce costs, eliminate errors, improved operational efficiencies and achieve regulatory compliance. *NARRATOR:Haemonetics cell salvage technology reduces the need for blood transfusions and improves patient outcomes. Hospitals are under tremendous pressure to maintain adequate blood inventory levels to satisfy transfusion needs. Our Cell Salvage technology reduces the demand for blood transfusions which reduces the costs to maintain blood inventories. Cell salvage also reduces the risks associated with transfusion related complications which can lead to longer hospital stays.*NARRATOR:Haemonetics businesses and products are focused in five segments: the Donor market, Commercial Plasma, the Patient market, Software Solutions & Services and Emerging Technology.

Next we will discuss each of these businesses and products. *NARRATOR:Donor products automate collection of platelets and red cells for transfusion. Donor customers are principally not-for-profit blood collectors and blood banks who collect red cells and platelets from volunteer donors. In many countries blood collection and blood banks are a branch of a national healthcare system. In the United States the American Red Cross accounts for approximately 46% of blood collections. The balance is collected by independent not-for-profit blood banks.

The Donor Division business model is to place devices at blood collection locations and sell the single use disposable set which is required for each donor collection. *NARRATOR:The blood bank product line is part of the Donor Division. Platelets, the blood component that aids in clotting, are most often used for transfusion to cancer patients whose own platelets have been damaged or destroyed by chemotherapy. The MCS+ 9000 system automates the collection of 1 to 2 units of platelets from a donor.

The ACP215 represents a major breakthrough in cell processing. This device prepares red blood cells for freezing using glycerol. Frozen red cells can be used for transfusion for at least 10 years after freezing. Cell washing removes the glycerol and most of the plasma proteins which reduces the risk of a negative reaction.*NARRATOR: The red cell product line is also part of the Donor Division. Red blood cells are the most frequently transfused blood component and are essential for many types of surgeries and medical treatments. The MCS+ 8150 and Cymbal systems automate the collection of two units of red cells. The Cymbal device is engineered for mobile blood collections. Both systems collect two units of red cells from one donor which allows collection agencies to double their red cell yield. *NARRATOR: Plasma is a straw-colored liquid that carries red blood cells, white blood cells and platelets. Plasma makes up 55% of blood and is collected primarily for manufacture into biopharmaceutical products. The process of manufacturing plasma into biopharmaceuticals is called fractionation. Over 25 million liters of plasma are fractionated annually worldwide. Plasma also benefits trauma patients, transplant recipients, and patients with clotting disorders.

*NARRATOR:The PCS2 system is Haemonetics' technology for the collection of plasma. This device Flexible protocols allow for the collection of "jumbo" units of platelet-poor plasma and platelet-poor plasma with optional saline replacement. The system is compact, lightweight, and user-friendly with built-in safety features.

*NARRATOR:Now lets discuss our Patient Division. Patient products automate suction and blood collection during and after surgery. This process, also known as surgical blood salvage or auto-transfusion, allows for blood lost during or after surgery to be collected, cleaned, and made available for re-infusion to the patient. This process is used worldwide in more than one million surgeries each year. *NARRATOR: The flagship of the Haemonetics auto transfusion product line is the Cell Saver. This system is the standard for blood salvage during rapid or high blood loss surgeries. It is designed for use in open heart surgery, vascular surgery, total joint replacement, spine surgery, trauma, and transplant surgery. Haemonetics invented surgical blood salvage nearly thirty years ago and has been an innovator in the field ever since.

The SmartSuction Harmony is a surgical blood suction system used to clear blood, fluid and debris from the surgical field. The system provides high air flow, self-regulating suction that optimizes removal of fluid at low suction levels. The device works as a companion product with our suite of blood salvage systems. *NARRATOR: The OrthoPAT is designed specifically to meet the auto transfusion needs of orthopedic surgery patients. This device provides both intraoperative and postoperative blood salvage. The OrthoPAT system is revolutionary in that orthopedic surgical patients, who historically have had to depend on donated blood, can now easily utilize their own blood.

The CardioPAT system is designed to meet the autotransfusion needs of cardiovascular surgery patients. Similar to the OrthoPAT, this device provides both intraoperative and postoperative blood salvage in a single disposable set. Both systems utilize Haemonetics dynamic disk technology. *NARRATOR: The TEG 5000 is the most comprehensive hemostasis analyzer available to clinicians to help prevent blood clotting complications. This product improves patient outcomes by reducing the need for allogeneic blood transfusions and benefits hospitals by preserving blood inventories. *NARRATOR: Now lets move to Software and Services. The Software and Services division provides hospitals and blood collectors with software applications, business services and blood management consulting. Our software and services are geared towards optimizing blood center and hospital processes and improving the effectiveness of the overall blood supply chain. *NARRATOR:Our software applications act as the main computer system or database that stores and manages all activities within a blood bank or plasma collection center. Regulatory mandates require rigorous controls to ensure that donor candidates are suitable for blood donation. Tight controls are also required for testing, quarantining, separating blood into its components and for releasing blood for transfusion. The entire process from qualifying donor candidates to releasing blood for transfusion is tracked by our software. The dependency on our software to achieve regulatory compliance is so high that the applications themselves are considered a medical device.*NARRATOR: Our commercial software products are eQue, Symphony, eLynx and Surround. eQue is a self-administered donor registration system, health history questionnaire and assessment tool that assists blood banks and plasma centers in determining donor eligibility. The eQue system works in both fixed and mobile blood drive environments.

The Symphony Suite gives blood centers both functionality and flexibility to track all donor, donation and blood unit information with the ability to accommodate increasingly stringent regulatory requirements.

eLynx is a hand-held system used by blood banks and plasma centers to automate donation floor operations and electronically capture real-time information. The system can be used for whole blood and apheresis collections and eliminates much of the paperwork traditionally found in donor operations.

And finally, Surround is an application used by blood laboratories to track samples and test results. Surround provides a secure, adaptable and reliable platform to handle time-critical and highly regulated laboratory needs.

*NARRATOR:Infonal is our Blood Management Consulting function. It provides IT tools that extract blood usage data from hospital IT systems. Our staff of clinicians and IT specialists use this data to advise surgeons on how to improve transfusion practices. This information is also used to make recommendations on how to utilize blood therapies to treat patients before surgery and to recover patient blood during surgery. *Narrator: We create strategic partnerships with our customers by offering consultative blood management solutions and business process excellence. These solutions allow our customers to deliver an enhanced donor experience and improve their customer service.

We offer innovative programs such as Six Sigma and Lean training, Industry Centric Programs and Customer Specific Programs. Our Six Sigma program implemented with the American Red Cross is credited with achieving $22million dollars in cost savings through improved efficiencies and waste reduction.

The Insight Model is a service provided to our customers that analyzes their blood center data, and makes recommendations on how to grow collections using automation and mobile efficiency.

*Narrator:Arryx is our Emerging Technology group. Arryx uses Holographic Optical Trapping technology to move and manipulate microscopic objects. This Holographic Optical Trapping or HOT technology uses laser beams and holograms to independently and in parallel hold, move, separate and manipulate hundreds of nanoscopic objects. The HOT technology is already a powerful laboratory tool used by researchers today. Future applications include blood screening and blood diagnostics as well as non-healthcare related applications. *

NARRATOR: Moscow, Russia, India, Chico, Vancouver, San Paolo, That concludes the review of our products and services. Now lets discuss where we are located. To support the global demand for our products and services, we have a global infrastructure consisting of over twenty locations throughout the world. Our corporate offices are located in the United States in Braintree, Massachusetts and we have regional offices in Signy, Switzerland, Tokyo, Japan and Hong Kong. In addition, we have sales and distribution facilities throughout the globe conducting business in more than 50 countries.

Our products our manufactured at company owned facilities in the United States and Scotland, we have relationships with several contract manufactures in Southeast Asia and we work with close to 100 Independent Distributors located on over 65 countries. *NARRATOR: We market our integrated blood management solution on a worldwide scale. As such, our revenues are distributed among various regions of the globe including North America, Europe and Japan and Asia. In the future, the distribution of revenue may shift as emerging markets continue to develop and existing markets continue to mature. Haemonetics is prepared to meet the changing global demand for blood management solutions. *NARRATOR:Since our inception, Haemonetics has developed Core Competencies that have been central to delivering high quality products and services that meet or exceed customer demands. A Core Competency is defined as a well performed, unique, internal activity or process that contributes significant value, confers a competitive advantage, and provides access to other market opportunities.

While our Core Competencies have greatly impacted our past achievements, they also represent the building blocks for future achievements. Core Competencies are critical to our continued success because they drive new product and service offerings that will deliver high quality growth, improved profitability and increased shareholder value.

Our Core Competencies have allowed us to achieve many significant and noteworthy accomplishments. As a company, we take pride in our Core Competencies and recognize their value, not only in what we they have enabled us to accomplish but also in what they will enable us to achieve in the future. *NARRATOR:Haemonetics has three core competencies. They are: Market Innovation, Manufacturing and Customer Service. Together, they work in unison to deliver value to customers, patients and shareholders. Lets look at each core competency individually.

*NARRATOR:The first core competency is Market Innovation. Haemonetics has a long history of market innovation. We have created and expanded virtually every market that we do business in. Our founder, Dr. Jack Latham, is regarded as a pioneer in automated blood processing. Through his early work with researchers from Harvard University, Dr. Latham created the first disposable blood processing bowl which led to the creation of the automated blood collection market and the surgical cell salvage market. Haemonetics has expanded these markets by introducing advanced blood processing technologies such as the Blow Molded Bowl and the Dynamic Disk. *NARRATOR: Our legacy of market innovation has continued to this day. Holographic Optical Trapping is a breakthrough technology that has the potential to reshape how blood collection and cell salvage procedures are performed in the future. The introduction of automated software solutions further advances our evolution into the leading provider of integrated blood management solutions. We have a reputation and an established track record of being a market innovator. We are intent on continuing this leadership into the future by providing integrated blood management solutions. *NARRATOR:Our second core competency is manufacturing. We are constantly monitoring our manufacturing processes to ensure the highest product quality, the highest product availability and lowest production costs. Central to our manufacturing competency is a focus on these three priorities. Manufacturing establishes clear goals relative to these three measurements and reviews them regularly to ensure broad alignment, ownership, and accountability.*NARRATOR:Quality expectations are established annually, driving continuous improvement in customer outcomes. This has been critical to our increasing market share in established businesses. At Haemonetics, Quality and Safety trumps all else. Key to achieving high quality production results are designing product quality into the production process, understanding and investing in key production technologies, quality training for all employees and employee involvement.*NARRATOR:Haemonetics operates in a dynamic global market. Ensuring that the right product, at the right time, to the right locations is no easy task. To do this we have developed an integrated processes to collect market signals and drive manufacturing and logistic activities. We maintain global distribution centers in the U.S., Europe, and in Asia to support regional business demands, and we typically maintain between 15 and 30 days of finished product inventory to absorb unplanned shifts in demand.*NARRATOR: Productivity and high efficiency levels result in lower production costs. We use Lean manufacturing to optimize processes and Six-Sigma tools to drive out variation, resulting in improved quality through more reliable processes. We apply relentless focus on productivity to ensure we are cost competitive in the market place. We have learned that by driving out waste and variability, both cost and quality improve. It is what we do every day.*NARRATOR:Our third core competency is Customer Service. As a medical device company we are expected to provide superior customer service. Our customers expect that knowledgeable service engineers will come to their site and service their equipment. They expect that orders will be taken accurately and deliveries will be complete and timely. We have a history of exceeding customer expectations and have differentiated ourselves by responding to non-standard requests. It is this kind of responsiveness and quickness to action that has allowed Haemonetics to earn multiple Omega North-face customer satisfaction awards.

*NARRATOR:The heart of our company and the uniqueness of our culture is a reflection of our core values. These values have long been part of our history and support both our vision and our key strategies. They define what we believe in and how we expect to conduct ourselves. Lets take a moment to reflect on each of these.*Narrator: Trust and Integrity is our most basic value. We expect Haemonetics employees to make the right choices and to go beyond the letter of the law in all that we do. There simply is no substitute for this and we walk the talk from the CEO to the lowest level of the organization. We try to be straightforward in our communications and transparent about why we make decisions and how we are performing.*NARRATOR:We exist to serve the needs of our customers and the patients who benefit from our products and services. We pay attention to health care practioners and direct our energy toward creating the products and services that improve patient care and deliver more cost-effective solutions.*NARRATOR: Our technology leadership is a function of innovation which started with our founder, Dr Jack Latham. Dr. Latham was inspired to invent a more effective way to collect blood after a friend, who was unable to receive an emergency blood transfusion, lost his life in an industrial accident. That same commitment to creating solutions for our customers drives our innovation efforts today. It drives us to be the global leader in blood management solutions for our customers.*NARRATOR: At Haemonetics we state simply and directly that: Quality is what we do, every day. There is strong resolve to making sure that our products are the safest and most reliable in the world today and that they will be even better tomorrow due to our rigorous attention to continuously improve whatever we make or do.*NARRATOR:We are making Haemonetics a great place to work. Our culture is dynamic. Our people around the world are smart, committed and dedicated. And while we all work hard, we also have fun. We pride ourselves on maintaining a strong team-orientation and rewarding performance. We are investing in tools like a state-of-the-art ERP platform and total value proposition sales skills which will help our employees to be fully prepared for a very competitive environment. We are confident in our future. For people who like to work hard and succeed without the drain of organizational politics and a lot of bureaucracy, this is really a great place to be at an extraordinarily exciting time.*NARRATOR:We are making Haemonetics a great place to work. Our culture is dynamic. Our people around the world are smart, committed and dedicated. And while we all work hard, we also have fun. We pride ourselves on maintaining a strong team-orientation and rewarding performance. We are investing in tools like a state-of-the-art ERP platform and total value proposition sales skills which will help our employees to be fully prepared for a very competitive environment. We are confident in our future. For people who like to work hard and succeed without the drain of organizational politics and a lot of bureaucracy, this is really a great place to be at an extraordinarily exciting time.*NARRATOR:We are making Haemonetics a great place to work. Our culture is dynamic. Our people around the world are smart, committed and dedicated. And while we all work hard, we also have fun. We pride ourselves on maintaining a strong team-orientation and rewarding performance. We are investing in tools like a state-of-the-art ERP platform and total value proposition sales skills which will help our employees to be fully prepared for a very competitive environment. We are confident in our future. For people who like to work hard and succeed without the drain of organizational politics and a lot of bureaucracy, this is really a great place to be at an extraordinarily exciting time.*NARRATOR:Next we will review blood facts. As mentioned previously, our integrated blood management solutions ensure the availability and safety of the worlds blood supply. To be successful in this effort it is necessary to understand the blood processing industry and the complexities of blood collection and blood salvage.*NARRATOR: Fact number one: Patients who need blood almost never receive transfusions of whole blood. Instead, they receive a transfusion of the blood component that their medical condition requires. Treating medical conditions with blood components is referred to as blood component therapy.

Blood is made up of several components, including: Red Blood Cells, Platelets and Plasma. Red Blood Cells account for approximately 40% of blood volume, carries oxygen throughout the body and is used in surgeries and trauma situations.

Platelets account for the smallest portion of blood volume and are used to control bleeding and to treat cancer and surgical patients.

Plasma accounts for 50% of blood volume and contains proteins which trigger blood clotting. Plasma is transfused directly to patients and is also use as a raw material for biopharmaceuticals. *NARRATOR:Fact number two: blood for transfusion can be processed in two very different ways.

The old fashioned way of turning whole blood into blood components is referred to as the manual collection of whole blood.

The more advanced method is to use state-of-the-art technology which automates the collection and separation process. *NARRATOR:The manual process for collecting blood components involves having a donor bleed whole blood, by gravity, into a blood bag. The result is a whole blood mixture of red cells, platelets and plasma. The blood bag is delivered to a processing laboratory where it is placed in a washing machine sized centrifuge. After the centrifuge begins spinning, the red blood cells begin to separate from the whole blood. After the first separation, another spin is done to separate the platelets from the plasma. Finally, the bags are squeezed manually until all three components are separated into individual bags. This process is time consuming, labor intensive, expensive and includes many opportunities for human error. *NARRATOR: The modern way to collect blood components eliminates the need to separate whole blood after it is collected at a remote laboratory. Instead, the separation is performed on-line while the donor is attached to the blood collection device. In this real time separation method, whole blood is drawn by a pump into a machine which holds a blood processing chamber which acts as a mini centrifuge. We refer to this blood processing chamber as a bowl, which sits inside the medical devices. *NARRATOR:The other high-tech way to automate the collection of red cells is to recover whole blood from a surgical patient immediately before, during or post surgery. Red cells that are collected with the whole blood that is shed from the wound are separated, washed, packed and hung on an IV pole and transfused right back to the bleeding patient. This is called surgical cell salvage, or sometimes Intraoperative Autologous Transfusion. Surgical patients who need blood prefer to receive a blood transfusion of their own red cells for the obvious reason that their own blood will never transmit the disease of another blood donor. The blood is fresh, available and always the right blood type.*NARRATOR:As noted, blood can be collected through manual or automated donations. However, today, the vast majority of red cells for transfusion to patients is still collected through manual methods.*NARRATOR:Blood Fact No 3 is that most blood is manufactured into components using the old fashioned method. Of the 60 million annual world wide blood collection procedures, 40 million are whole blood using manual, non-automated procedures. The whole blood collected using this procedure is then separated into components at the processing lab.

This concludes the general review of blood facts. Now, a final word from Brad Nutter, CEO of Haemonetics. *NARRATOR:Hello, Im Brian Concannon and let me welcome you to Haemonetics. As you have learned, for over thirty years Haemonetics has worked to establish itself as the global leader in ensuring the safety and availability of the worlds blood supply. In doing so we have earned a reputation for innovation, high quality manufacturing and exceptional customer service. It is these three competencies, driven by the collective efforts of a dedicated, global workforce that will enable us to achieve our vision of being the global leader in blood management solutions for our customers.

Now, this is no small task but one that we are fully confident that we can achieve. We are a company that is uniquely positioned to expand and strengthen our reputation as an innovator in providing healthcare solutions to our customers. Never has Haemonetics been more prepared to deliver exceptional value to our customers, our shareholders and most importantly, our employees.

On behalf of the entire organization, welcome to Haemonetics. You have joined a great corporation with a very bright future. We wish you the best of success in your career and we look forward to working together to achieve our vision.

Haemonetics Presentation

Documents

Transcript of Haemonetics Presentation